Quantcast
Last updated on April 18, 2014 at 16:31 EDT

Latest Perrigo Company Stories

2012-06-08 06:26:01

ALLEGAN, Mich., June 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the William Blair Growth Stock Conference on Thursday, June 14, at 8:00 AM (CDT) in Chicago, IL. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx)...

2012-06-06 06:25:45

ALLEGAN, Mich., June 6, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for calcium acetate capsules, the generic equivalent of Phoslo® Gelcaps. Perrigo was previously in patent litigation over this product with the brand and the litigation settled in late 2011. The terms of the settlement are confidential. (Logo:...

2012-05-30 06:26:23

ALLEGAN, Mich., May 30, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that the U.S. Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application (ANDA) for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser's Delsym® suspension. As the exclusive marketer and distributor of this product for the store brand over-the-counter (OTC) market in the United...

2012-05-24 10:23:57

ALLEGAN, Mich., May 24, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and Chief Executive Officer, Joseph C. Papa, will present at the Jefferies Global Healthcare Conference on Monday, June 4, at 9:00 AM (EDT) in New York City, New York. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo Executive Vice President and Chief Financial Officer, Judy L. Brown, will present at the Goldman Sachs Global Healthcare...

2012-05-22 10:24:45

ALLEGAN, Mich., May 22, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for butoconazole nitrate 2% vaginal cream, the generic equivalent of Gynazole·1®. Perrigo was the first applicant to submit a substantially complete ANDA with a paragraph IV certification and is entitled to 180-days of marketing exclusivity. Perrigo is working...

2012-05-18 10:26:41

ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole capsules (15 mg). Shipments of product to customers have already begun. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) This new product for the U.S. store brand market is bioequivalent to Novartis' Prevacid® 24HR capsules (15 mg)...

2012-05-15 06:29:08

ALLEGAN, Mich., May 15, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer, Judy L. Brown, will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 15, at 10:00 AM (PDT) in Las Vegas, NV. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic...

2012-05-08 02:28:41

ALLEGAN, Mich., May 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its third quarter ended March 31, 2012. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO) Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our record fiscal third quarter revenue and earnings performance. These strong results were made possible by the continued operational excellence of the team. Headlining this execution were...

2012-04-24 06:26:39

ALLEGAN, Mich., April 24, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it will release financial results for its third quarter fiscal 2012 on Tuesday, May 8, 2012 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) The conference call will be available...

2012-04-12 10:22:37

ALLEGAN, Mich., April 12, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg (a generic version of Mucinex® 600mg tablets) product. This launch consists of product packaged in bottles to a number of customers. The company expects to initiate its full-scale over-the-counter (OTC) launch of product in blister packaging to its retail and wholesale customers in store brand or own...